- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Heart Test Laboratories, Inc.: HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG | 1 | GlobeNewswire (USA) | ||
| 02.04. | Heart Test Laboratories, Inc.: HeartSciences to Present at the LD Micro Invitational XIV Conference | 1 | GlobeNewswire (USA) | ||
| 26.03. | Heart Test Laboratories, Inc.: HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients | 1 | GlobeNewswire (USA) | ||
| 14.03. | Recap: Heart Test Laboratories Q3 Earnings | 1 | Benzinga.com | ||
| 14.03. | Heart Test Laboratories reports Q3 results | 1 | Seeking Alpha | ||
| 14.03. | Heart Test Laboratories, Inc.: HeartSciences Reports Third Quarter Fiscal 2024 Financial Results | 111 | GlobeNewswire (Europe) | Southlake, TX, March 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered... ► Artikel lesen | |
| 14.03. | Heart Test Laboratories, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.03. | Heart Test Laboratories, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 12.03. | Heart Test Laboratories, Inc.: HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes | 1 | GlobeNewswire (USA) | ||
| 06.03. | Why Is Heart Test Laboratories (HSCS) Stock Down 21% Today? | 1 | InvestorPlace | ||
| 06.03. | Heart Test Laboratories, Inc.: HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology | 1 | GlobeNewswire (USA) | ||
| 05.03. | Heart Test Laboratories files to sell 34.68M shares for holders | 1 | Seeking Alpha | ||
| 05.03. | Heart Test Laboratories, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
| 26.02. | Heart Test Laboratories, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 26.02. | Heart Test Laboratories, Inc.: HeartSciences Adds Key Advisor to its Scientific Advisory Board | 1 | GlobeNewswire (USA) | ||
| 15.02. | Heart Test Laboratories, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.02. | Heart Test Laboratories, Inc.: HeartSciences Expands its Scientific Advisory Board | 1 | GlobeNewswire (USA) | ||
| 25.01. | Heart Test Laboratories, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.01. | Heart Test Laboratories, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 03.01. | Heart Test Laboratories, Inc.: HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting | 1 | GlobeNewswire (USA) |
Seite:
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ORPEA | 11,854 | -4,82 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
| NANO-X IMAGING | 9,100 | 0,00 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| BUTTERFLY NETWORK | 0,707 | 0,00 % | ThinkSono Ltd: ThinkSono Releases Real-Time DVT AI Training Solution for Butterfly Network's Handheld Ultrasound Devices | LONDON, ENGLAND / ACCESSWIRE / April 23, 2024 / ThinkSono, a pioneering provider of AI-driven medical imaging solutions, is proud to announce the release of ThinkSono AI Training, a deep vein thrombosis... ► Artikel lesen | |
| GOODRX | 6,960 | 0,00 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
| JOINT CORP | 12,280 | 0,00 % | The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results | ||
| CARMAT | 3,215 | -12,16 % | CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024 | 2023 sales of €2.8 million, i.e. 17 Aeson® implants, including 11 in the last quarter
2024 sales forecast of around €14 million
Active exploration of financing options to extend... ► Artikel lesen | |
| HYPERFINE | 0,810 | 0,00 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROGYNY | 32,600 | 0,00 % | Progyny, Inc. Announces Third Quarter 2023 Results | Record Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Sales Season Produces 1.3 Million New Covered Lives... ► Artikel lesen | |
| MIMEDX | 6,430 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results | Net Sales Grew 17% Year-Over-Year for the Fourth Quarter and 20% for the Full Year Fourth Quarter Net Income was $53 million, Inclusive of a $40 million One-Time Non-Cash Tax Benefit Fourth Quarter... ► Artikel lesen | |
| BIOMERICA | 0,713 | 0,00 % | Biomerica, Inc.: Biomerica Reports Third Quarter 2024 Financial Results | Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented... ► Artikel lesen | |
| ATRION | 394,00 | +4,79 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen | |
| ATRICURE | 23,050 | 0,00 % | AtriCure upgraded at Oppenheimer on valuation | ||
| AMWELL | 0,531 | 0,00 % | Amwell Receives Continued Listing Standard Notice From NYSE | Boston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York... ► Artikel lesen | |
| TALKSPACE | 3,070 | 0,00 % | Talkspace Announces Third Quarter 2023 Results | B2B payor revenue grew 132% year-over-year 3Q 2023 Operating expenses of $24.0 million, down 30% year-over-year Reduced Net Loss to $4.4 million and Adjusted EBITDA1 loss to $2.8 million, an improvement... ► Artikel lesen | |
| OUTSET MEDICAL | 2,550 | 0,00 % | Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis |
Das Unternehmen HEART TEST LABORATORIES INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,108 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
